EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

A Modification to Two‐Stage Least Squares With Genetic Applications

Lei Fang, Wei Pan iD

Statistics in Medicine · 2025

DOI: 10.1002/sim.70308 ↗

At a glance

Journal article in Statistics in Medicine, 2025. Written by Lei Fang and 1 co-authors. Institution: Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Genome-Wide Association Study. 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Two‐stage least squares (2SLS) is by default applied to infer a putative causal association between an exposure, such as a gene or a protein, with an outcome such as a complex disease or trait, in transcriptome‐ or proteome‐wide association studies (TWAS/PWAS). In a typical two‐sample setting for TWAS/PWAS, the stage 1 sample size is much smaller than that of stage 2. To reduce the resulting attenuation bias and estimation uncertainty in stage 1 and boost the statistical power of the conventional TWAS, we propose a new method, called reverse two‐stage least squares (r2SLS): Instead of imputing a gene's expression (using genetic variants as instrumental variables, IVs) in stage 1 and then testing the association between the imputed expression and the observed outcome in stage 2 in the conventional 2SLS approach, we propose predicting the outcome (using IVs) and testing the association between the predicted outcome and the observed gene expression. Theoretically, we establish that the r2SLS estimator is asymptotically unbiased with a normal distribution. We also show theoretically when 2SLS and r2SLS are asymptotically equivalent and when r2SLS is asymptotically more efficient than 2SLS. We also consider the practical issue of how to select invalid IVs. We use simulations and three real data examples based on the GTEx gene expression data, UKB‐PPP proteomic data, and several GWAS summary datasets to demonstrate some advantages of r2SLS over 2SLS, including possibly better type I error control, higher statistical power and robustness to weak IVs.

Subjects

MeSH terms (MEDLINE)

Genome-Wide Association StudyHumansLeast-Squares AnalysisComputer SimulationTranscriptomeModels, StatisticalSample Size

Author keywords

2slscausal inferenceinstrumental variable regressionr2slstwas

Authors and institutions

  • Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID profiles: Wei Pan

Funding

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Fang, L., & Pan, W. (2025). A Modification to Two‐Stage Least Squares With Genetic Applications. Statistics in Medicine. https://doi.org/10.1002/sim.70308

Vancouver

Fang L, Pan W. A Modification to Two‐Stage Least Squares With Genetic Applications. Statistics in Medicine. 2025. doi:10.1002/sim.70308

BibTeX
@article{Fang2025,
  author = {Fang, Lei and Pan, Wei},
  title = {A Modification to Two‐Stage Least Squares With Genetic Applications},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70308}
}
Start for free →